Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03157492 · ClinicalTrials.gov registry record · NA
Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology
A NA study of Hearing Loss and Deafness, sponsored by Gallaudet University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 5
- Study locations
NCT03157492: Completed NA study of Hearing Loss and Deafness, sponsored by Gallaudet University.
NCT03157492 is a NA study of Hearing Loss and Deafness that has completed, run by Gallaudet University. The registered enrollment target is 20 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03157492, a NA study of Hearing Loss and Deafness, has completed, sponsored by Gallaudet University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study evaluates the benefits of short-term training via telehealth for post-lingually deafened adult cochlear implant users. Half the participants will receive aural rehabilitation and the other half cognitive training. The hypothesis is that short-term aural rehabilitation via telerehab technology will improve outcomes for post-lingually deafened cochlear implant users
Primary Outcome
Percent correct scores on CasperSent topic-related recorded sentences.
Conditions Studied
Interventions
- BEHAVIORAL Aural Rehabilitation Group
- BEHAVIORAL Cognitive Training Group
Study Locations (5)
District of Columbia
- Gallaudet University - Washington D.C.
Florida
- University of South Florida - Tampa
Maryland
- University of Maryland - College Park
New York
- Columbia University - New York
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2021-10-13 |
| Phase | NA |
What the finished NCT03157492 record still lists
NCT03157492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Aural Rehabilitation Group is the first listed.
NCT03157492 lists 5 locations in 5 states (District of Columbia, Florida, Maryland).
Frequently Asked Questions
What is clinical trial NCT03157492 about?
NCT03157492 is a clinical study titled "Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology". This study evaluates the benefits of short-term training via telehealth for post-lingually deafened adult cochlear implant users. Half the participants will receive aural rehabilitation and the other half cognitive training. The hypothesis is that short-term aural rehabilitation via telerehab techno...
What is the current status of trial NCT03157492?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-02. Estimated completion is 2021-10-13.
What conditions does trial NCT03157492 study?
This clinical trial studies the following conditions: Hearing Loss, Deafness.
What interventions are being tested in trial NCT03157492?
The interventions under investigation include: Aural Rehabilitation Group (BEHAVIORAL), Cognitive Training Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03157492?
This trial is sponsored by Gallaudet University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03157492 being conducted?
This trial has 5 study locations across District of Columbia, Florida, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03157492's enrollment target sits among peer trials
20 57th of 58 higher than 1 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI